Today, we're going to talk about how to cure the silent killer hepatitis for only a thousand

dollars per pill. Now, the catches you have to take this for roughly about three months.

And roughly, there's a little more than 90 days in three months. So that comes out to

90,000 dollars. Now, before I get into the cure, let's talk about what hepatitis is. It's

inflammation of the liver. We're primarily going to be discussing viral hepatitis, okay? But there's

also other causes of hepatitis, like an autoimmune, which could be triggered by various things.

It could be triggered by a virus, vaccine, some drug, or other things. But there's a lot of people

who have hepatitis. It's like 325 million people worldwide have hepatitis. And the problem is,

there's not a lot of clues or symptoms to give it away. That's why they call a silent killer,

because you don't know what's going on. So what's happening is the virus ghost your immune system,

which means it hides within our immune system below the radar so it can't be detected. And at the

same time, it hijacks our own immune system. So our immune system's antiviral weaponry cannot

be activated. So it paralyzes our immune system so we can't bite back while it creates a lot of

destruction. And over time, that viral destruction then turns into inflammation and possibly into

fibrosis. So the cure. It's a drug called solvalde. Now they do use other medications with this

medication. But solvalde has a pretty high success rate for hepatitis type C. And the definition

for successfully treated apparently means curing. And so the curate or successful treatment

is roughly between 80 to 86%. Now the problem with this drug, number one, is the cost. It's a

thousand dollars per pill. And a person could spend anywhere between 80,000 to 160,000 dollars

for a round of treatment. Now the question I have is why is it so darn expensive? Well,

there applies the R&D. It takes a lot of money to develop this drug. But there's a very interesting

paper I'm going to put in the description that talks about the funding that they get in their R&D.

...